The Absorb bioresorbable vascular scaffold (Absorb BVS, Abbott Vascular, Santa Clara, California) promises to address some of the residual shortcomings of existing metallic stents, such as late events induced by permanent caging of the coronary vessel. Scaffold restenosis (ScR) of BVS has been poorly described so far and treatment strategies for this event remain to be codified. We report on a case series of 14 lesions in 12 patients presenting with ScR and discuss their anatomical features and management strategies. © 2015 Wiley Periodicals, Inc.
Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry.
CAPODANNO, DAVIDE FRANCESCO MARIA
;Capranzano P;TAMBURINO, Corrado
2015-01-01
Abstract
The Absorb bioresorbable vascular scaffold (Absorb BVS, Abbott Vascular, Santa Clara, California) promises to address some of the residual shortcomings of existing metallic stents, such as late events induced by permanent caging of the coronary vessel. Scaffold restenosis (ScR) of BVS has been poorly described so far and treatment strategies for this event remain to be codified. We report on a case series of 14 lesions in 12 patients presenting with ScR and discuss their anatomical features and management strategies. © 2015 Wiley Periodicals, Inc.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
ccd.25819.pdf
solo gestori archivio
Tipologia:
Versione Editoriale (PDF)
Dimensione
786.8 kB
Formato
Adobe PDF
|
786.8 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.